Should You Buy These Vaccine Stocks After the Sell-Off?
Coronavirus vaccine makers led gains in healthcare stocks last year. And the trend didn't stop as the world rang in the new year. Many of these companies charged full speed ahead into 2021. And for good reason. Some of them began generating revenue from vaccines. Others moved closer to bringing a potential vaccine to market.
But recently, excitement around some of the biggest winners has started to fade. Now, the big question is whether share price declines represent a buying opportunity -- or a sign to flee the stock. Let's take a look at three of the biggest movers.
Image source: Getty Images.
Source Fool.com
